Priscilla VanderVeer Priscilla VanderVeer Priscilla VanderVeer is a vice president, public affairs, at PhRMA. Ms. VanderVeer has more than 15 years of experience communicating important health care issues to a wide variety of audiences, including medical, health and patient advocates; policymakers and opinion-leaders; and the general public. At PhRMA, Ms. VanderVeer leads the development and execution of communications strategies and activities for the organization’s key state advocacy priorities. She lives in Annapolis, Maryland with her husband, Ken and their two dogs: Bea Arthur, a tiny 5 lb. Maltese and Henry, a slightly larger-than-average Yorkshire Terrier.
Recent Posts
Week in review: The latest from PhRMA
By Priscilla VanderVeer | February 19, 2016
Coverage does not equal access: While the burden of high deductibles has already received significant attention, new data reveals that consumers have no choice but to pay up to thousands of...
Read More
Week in Review: The latest from PhRMA
By Priscilla VanderVeer | February 12, 2016
Today’s “Week in Review” covers the last two weeks of activity here at PhRMA. As you’ll see, we’ve been busy! We’re Fighting Back: Our new From Hope to Cures ad campaign launched on Monday. In it,...
Read More
Week in Review: The latest from PhRMA
By Priscilla VanderVeer | January 29, 2016
Record number of new medicines in 2015: The FDA’s Center for Drug Evaluation and Research’s (CDER) fifth annual Novel New Drugs Summary approved a record 45 new medicines in 2015, marking the...
Read More
Week in review: The latest from PhRMA
By Priscilla VanderVeer | January 8, 2016
Rising deductibles and out-of-pocket costs: A new Kaiser Family Foundation/New York Times survey outlined the challenges Americans, even those with insurance, are having with medical bills. The...
Read More
Local Impact: Hepatitis C and Medicaid spending
By Priscilla VanderVeer | December 22, 2015
There has been a lot of discussion about the cost of new hepatitis C treatments to state Medicaid programs. What has not been addressed, however, is how those costs stack up against older, less...
Read More
Week in Review: The Latest from PhRMA
By Priscilla VanderVeer | December 18, 2015
Biologics and Biosimilars: PhRMA launched a new section of its website this week to provide educational resources on biologics and biosimilars. Check it out now. Ask About Adherence: Recent...
Read More
Policies to combat prescription drug abuse and misuse
By Priscilla VanderVeer | December 15, 2015
There has been a lot of discussion recently about prescription drug abuse, and rightfully so. Each day, almost 7,000 people are treated in emergency departments for using prescription opioid drugs...
Read More
Week in Review: The Latest from PhRMA
By Priscilla VanderVeer | December 11, 2015
Part D’s Six Protected Classes: The latest Conversations forum asks leading health experts why Medicare Part D’s protected classes are important for patients. See what they had to say. Critics...
Read More
Week in Review: The Latest from PhRMA
By Priscilla VanderVeer | December 4, 2015
Ask About Adherence: A recent study from the American Journal of Preventive Medicine found proper adherence to hypertension medication leads to time, money and resources saved for both patients...
Read More
Week in Review: The Latest from PhRMA
By Priscilla VanderVeer | November 20, 2015
Value of Medicine: Insurers continue to attack medicines and make it difficult for patients to access the drugs prescribed by their doctors. One patient shares his story about the difficulties...
Read More
Medicare Monday (100)
340B Spotlight (46)
Cost & Consequence (0)
